Chronic exposure to random restraint stress retards the development of estrogen-induced pituitary prolactinoma in rats.
The effects of stress on carcinogenesis have been equivocal. The present work examined the influence of an unpredictable pattern of chronic restraint stress on estradiol-induced pituitary hyperplasia in male Fischer 344 rats. The animals were grouped as follows: (1) control, (2) stressed, (3) estradiol (31 mg), subcutaneous implant for 40 days and (4) estradiol with stress, 1 h daily, randomly, for 40 days. The pituitaries increased markedly in mass in groups 3 and 4 compared to the first two groups. However, the gland weight in rats exposed to estradiol plus stress was significantly (P less than 0.04) reduced as compared to estradiol per se. Prolactin levels increased due to estradiol treatment and decreased following exposure to stress. Weights of adrenal glands increased as a result of estradiol treatment when compared to those in stressed or untreated animals. This adrenal hypertrophy correlated well with plasma corticosterone levels. The data demonstrate that chronic immobilization stress retarded estradiol-induced pituitary prolactinoma. Modulation of the immune response by stress-related factors may play a role in the inhibition of tumorigenesis.
Gottesfeld
Z
Z
Department of Neurobiology and Anatomy, University of Texas Medical School at Houston, TX 77025.
Liehr
J G
JG
D000818:Animals; D004958:Estradiol / Q000494:pharmacology*; D008297:Male; D010902:Pituitary Gland / Q000187:drug effects*; D010911:Pituitary Neoplasms / Q000378:metabolism*; D011388:Prolactin / Q000378:metabolism*; D051381:Rats; D011916:Rats, Inbred F344; D012149:Restraint, Physical; D013312:Stress, Physiological / Q000503:physiopathology*
D004958:Estradiol; D011388:Prolactin